We recently published a list of 20 Stocks Insiders Were Buying In Q1 2025. In this article, we are going to take a look at where Zomedica Corp. (OTCQB:ZOMDF) stands against other stocks insiders were buying in Q1 2025.
About 30 minutes before the market closed Monday, the broader market index was up 0.3%, while the blue-chip companies gained 0.9%. Meanwhile, the Nasdaq Composite dropped 0.5%. Some stocks were recovering from Friday losses after inflation data came in higher than expected, coupled with weak consumer sentiment, which heightened concerns about the U.S. economy’s stability, according to Investopedia.
As investors react to daily market changes, ongoing uncertainty continues to affect the market. During such times, insider trading often garners attention, as executive purchases of company stock can signal optimism about the company’s prospects. However, insider sales do not always indicate a lack of confidence—they may be influenced by personal financial reasons or a need for diversification. Executives often follow pre-arranged plans, like 10b5-1, to ensure transparency. While insider trading can offer valuable insights, it should be considered alongside a company’s financial health, market conditions, and industry shifts.
Our Methodology
What are some of the stocks insiders have been buying the most in the first quarter of the year? To find out, we used Insider Monkey’s insider trading stock screener, focusing only on stocks where at least five insiders had purchased shares in January, February, and March. From there, we ranked the 20 stocks with the highest number of insiders purchasing shares.
Our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds, focusing on insider trading and stock picks from hedge fund investor newsletters and conferences. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
With each stock, we note the average price per share of these purchases and the stock’s market capitalization.
An operating theatre with medical personnel and a patient in pre-op for a Neuro-Spinal Scaffold Implant.
Zomedica Corp. (OTCQB:ZOMDF)
Market Cap: $56.84 million
Number of insiders buying: 8
Zomedica is a veterinary health company based in Ann Arbor, Michigan. The company specializes in diagnostic and therapeutic products for companion animals, offering solutions like TRUFORMA and TRUVIEW diagnostic platforms, along with PulseVet and Assisi Loop devices for pain and inflammation treatment. Zomedica also works with Celsee, Inc. and Seraph Biosciences, Inc. to develop advanced diagnostic and pathogen detection technologies. It is also one of the 15 cheapest stocks insiders are purchasing in March.
For the full year 2024, Zomedica reported revenue of $27.3 million, up from $25.2 million in 2023. Operating expenses reached $70.1 million, reflecting a full year of costs associated with Qorvo Biotechnologies, compared to $60.6 million the previous year. Research and development expenses increased to $7.3 million from $5.8 million in 2023, while the net loss widened to $47.0 million, compared to a loss of $34.5 million in 2023.
In March, eight insiders, including the company’s CEO, and COO, acquired a total of around $375,385 worth of Zomedica shares at an average price of $0.07 per share. Currently, the stock trades at $0.054 per share, having dropped 55% year-to-date, and 61.43% over the past 12 months.
According to MarketBeat, one analyst rates Zomedica stock as a “Moderate Buy” with a price target of $0.25 per share. The average price target suggests a 362.96% upside from the latest price.
Overall, ZOMDF ranks 9th on our list of stocks insiders were buying in Q1 2025. While we acknowledge the potential of ZOMDF our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than ZOMDF but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure: None. This article is originally published at Insider Monkey.
